Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo

Journal of Virology

Volumn 81, Issue 22, 2007, Pages 12249-12259

  Di Paolo, Nelson C ^a   Kalyuzhniy, Oleksandr ^a   Shayakhmetov, Dmitry M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INTERLEUKIN 6; LYSYLLYSYLTHREONYLLYSINE; PROTEOHEPARAN SULFATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; ADENOVIRUS 31; ADENOVIRUS 41; ADENOVIRUS 5; AMINO ACID SEQUENCE; ARTICLE; CELL ADHESION; CELL SPECIFICITY; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERNALIZATION; LIVER CELL; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN MOTIF; TISSUE SPECIFICITY; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE; VIRUS HEPATITIS; VIRUS INFECTIVITY;

ADENOVIRIDAE; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CAPSID PROTEINS; CELL LINE, TUMOR; GENETIC VECTORS; HEPARIN; HEPATOCYTES; HUMANS; KUPFFER CELLS; MICE; MOLECULAR SEQUENCE DATA; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; MUS;

EID: 36048936449     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01584-07     Document Type: Article

References (51)

1. Alemany, R., and D. T. Curiel. 2001. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 8:1347-1353.
2. Baker, A., J. H. McVey, S. N. Waddington, N. C. Di Paolo, and D. M. Shayakhmetov. 2007. The influence of blood on in vivo adenovirus biodistribution and transduction. Mol. Ther. 15:1410-1416.
3. Bayo-Puxan, N., M. Cascallo, A. Gros, M. Huch, C. Fillat, and R. Alemany. 2006. Role of the putative heparan sulfate glycosaminoglycan- binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting. J. Gen. Virol. 87:2487-2495.
4. Bergelson, J. M. 1999. Receptors mediating adenovirus attachment and internalization. Biochem. Pharmacol. 57:975-979.
5. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
6. Brunetti-Pierri, N., D. J. Palmer, A. L. Beaudet, K. D. Carey, M. Finegold, and P. Ng. 2004. Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum. Gene Ther. 15:35-46.
7. Dechecchi, M. C., P. Melotti, A. Bonizzato, M. Santacatterina, M. Chilosi, and G. Cabrini. 2001. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J. Virol. 75:8772-8780.
8. Dechecchi, M. C., A. Tamanini, A. Bonizzato, and G. Cabrini. 2000. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 268:382-390.
9. Gaggar, A., D. Shayakhmetov, and A. Lieber. 2003. CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9:1408-1412.
10. Goosney, D. L., and G. R. Nemerow. 2003. Adenovirus infection: taking the back roads to viral entry. Curr. Biol. 13:R99-R100.
11. Gravell, M., W. T. London, S. A. Houff, D. L. Madden, M. C. Dalakas, J. L. Sever, K. G. Osborn, D. H. Maul, R. V. Henrickson, P. A. Marx, N. W. Lerche, S. Prahalada, and M. B. Gardner. 1984. Transmission of simian acquired immunodeficiency syndrome (SAIDS) with blood or filtered plasma. Science 223:74-76.
12. Greber, U. F., M. Suomalainen, K. Boucke, and R. Stidwlll. 1997. Entry of adenovirus: the role of the cytoskeleton. Mol. Biol. Cell 8:S676.
13. Greber, U. F., M. Willetts, P. Webster, and A. Helenius. 1993. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477-486.
14. Hartwell, W. V., G. J. Love, and M. P. Eidenboc. 1966. Adenovirus in blood clots from cases of infectious hepatitis. Science 152:1390.
15. 3. Blood 92:S171A.
16. Hodges, B. L., K. M. Taylor, Q. M. Chu, S. E. Scull, R. G. Serriello, S. C. Anderson, F. Wang, and R. K. Scheule. 2005. Local delivery of a viral vector mitigates neutralization by antiviral antibodies and results in efficient transduction of rabbit liver. Mol. Ther. 12:1043-1051.
17. Kojaoghlanian, T., P. Flomenberg, and M. S. Horwitz. 2003. The impact of adenovirus infection on the immunocompromised host. Rev. Med. Virol. 13:155-171.
18. Kritz, A. B., C. G. Nicol, K. L. Dishart, R. Nelson, S. Holbeck, D. J. Von Seggern, L. M. Work, J. H. Mcvey, S. A. Nicklin, and A. H. Baker. 2007. Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loop. Mol. Ther. 15:741-749.
19. Law, L. K., and B. L. Davidson. 2005. What does it take to bind CAR? Mol. Ther. 12:599-609.
20. Li, E., D. G. Stupack, G. M. Bokoch, and G. R. Nemerow. 1998. Adenovirus cell entry requires the Rho family of small GTPases. Mol. Biol. Cell 9:S344A.
21. v integrins requires phosphoinositide-3-OH kinase. J. Virol. 72:2055-2061.
22. Lievens, J., J. Snoeys, K. Vekemans, S. Van Linthout, R. de Zanger, D. Collen, E. Wisse, and B. De Geest. 2004. The size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction after adenoviral gene transfer. Gene Ther. 11:1523-1531.
23. Medina-Kauwe, L. K. 2003. Endocytosis of adenovirus and adenovirus capsid proteins. Adv. Drug Deliv. Rev. 55:1485-1496.
24. Meier, O., and U. F. Greber. 2003. Adenovirus endocytosis. J. Gene Med. 5:451-462.
25. Mittereder, N., K. L. March, and B. C. Trapnell. 1996. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70:7498-7509.
26. v integrins in adenovirus cell entry and gene delivery. Microbiol. Mol. Biol. Rev. 63:725-734.
27. Ni, S., K. Bert, A. Gaggar, Z.-Y. Li, H.-P. Kiem, and A. Lieber. 2005. Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons. Hum. Gene Ther. 16:664-677.
28. Nicklin, S. A., E. Wu, G. R. Nemerow, and A. H. Baker. 2005. The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol. Ther. 12:384-393.
29. Nicol, C. G., D. Graham, W. H. Miller, S. J. White, T. A. G. Smith, S. A. Nicklin, S. C. Stevenson, and A. H. Baker. 2004. Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats. Mol. Ther. 10:344-354.
30. Park, B. H., J. H. Lee, J. S. Jeong, S. H. Rha, S. E. Kim, J. S. Kim, J. M. Kim, and T. H. Hwang. 2005. Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytes. Cancer Gene Ther. 12:116-121.
31. Parker, A. L., S. N. Waddington, C. G. Nicol, D. M. Shayakhmetov, S. M. Buckley, L. Denby, G. Kemball-Cook, S. H. Ni, A. Lieber, J. H. McVey, S. A. Nicklin, and A. H. Baker. 2006. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108:2554-2561.
32. Pringakerblom, P., and T. Adrian. 1995. Sequence characterization of the adenovirus-31 fiber and comparison with serotypes of subgenera A to F. Res. Virol. 146:343-354.
33. Roelvlnk, P. W., A. Lfzonova, J. G. Lee, Y. Li, J. M. Bergelson, R. W. Flnberg, D. E. Brough, I. Kovesdi, and T. J. Wickham. 1998. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 72:7909-7915.
34. Roelvink, P. W., G. Mi Lee, D. A. Einfeld, I. Kovesdi, and T. J. Wickham. 1999. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286:1568-1571.
35. Ruuskanen, O., O. Meurman, and G. Akusjarvi. 2002. Adenoviruses, p. 515-534. In Douglas D. Richman, Richard J. Whitley, and Frederick G. Hayden (ed.), Clinical virology, 2nd ed. ASM Press, Washington, DC.
36. Schoggins, J. W., J. G. D. Gall, and E. Falck-Pedersen. 2003. Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. J. Virol. 77:1039-1048.
37. Segerman, A., J. P. Atkinson, M. Marttila, V. Dennerquist, G. Wadell, and N. Arnberg. 2003. Adenovirus type 11 uses CD46 as a cellular receptor. J. Virol. 77:9183-9191.
38. Shayakhmetov, D. M., A. L. Eberly, Z. Y. Li, and A. Lieber. 2005. Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J. Virol. 79:1053-1061.
39. Shayakhmetov, D. M., A. Gaggar, S. H. Ni, Z. Y. Li, and A. Lieber. 2005. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 79:7478-7491.
40. Shayakhmetov, D. M., Z. Y. Li, S. Ni, and A. Lieber. 2004. Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J. Virol. 78:5368-5381.
41. Shayakhmetov, D. M., Z. Y. Li, S. H. Ni, and A. Lieber. 2005. Interference with the IL-1-signaling pathway improves the toxicity profile of systemically applied adenovirus vectors. J. Immunol. 174:7310-7319.
42. Shayakhmetov, D. M., and A. Lieber. 2000. Dependence of adenovirus infectivity on length of the fiber shaft domain. J. Virol. 74:10274- 10286.
43. + cells by a retargeted adenovirus vector. J. Virol. 74:2567-2583.
44. Smith, T., N. Idamakanti, H. Kylefjord, M. Roffence, L. King, M. Kaloss, M. Kaleko, and S. C. Stevenson. 2002. In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor. Mol. Ther. 5:770-779.
45. Smith, T. A., N. Idamakanti, J. Marshall-Neff, M. L. Roffence, P. Wright, M. Kafoss, L. King, C. Mech, L. Dinges, W. O. Iverson, A. D. Sherer, J. E. Markovits, R. M. Lyons, M. Kaleko, and S. C. Stevenson. 2003. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. Hum. Gene Ther. 14:1595-1604.
46. Smith, T. A., N. Idamakanti, M. L. Rollence, J. Marshaff-Neff, J. Kim, K. Mulgrew, G. R. Nemerow, M. Kaleko, and S. C. Stevenson. 2003. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum. Gene Ther. 14:777-787.
47. Steiner, I., C. Aebi, A. Ridolfi Luthy, B. Wagner, and K. Leibundgut. 2 February 2007, posting date. Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr. Blood Cancer. doi:10.1002/pbc.21120.
48. Stone, D., Y. Liu, Z.-Y. Li, and A. Lieber. 2007. Comparison of blood interaction and organ biodistribution for adenoviruses from species B, C, E and F. Mol. Ther. 15:S331.
49. Stupack, E. L. D., G. M. Bokoch, and G. R. Nemerow. 1998. Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J. Virol. 72:8806-8812.
50. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
51. Wu, E., L. Pache, D. J. Von Seggern, T. M. Mullen, Y. Mikyas, P. L. Stewart, and G. R. Nemerow. 2003. Flexibility of the adenovirus fiber is required for efficient receptor interaction. J. Virol. 77:7225-7235.